Prothena Corp. plc diskutieren
Prothena Corp. plc
WKN: A1KAVV / Symbol: PRTA / Name: Prothena Corp / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
7,50 €
-0,66 %
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $48.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $40.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its price target raised by analysts at Piper Sandler from $94.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $40.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at HC Wainwright from $48.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at HC Wainwright from $30.00 to $14.00. They now have a "buy" rating on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at Chardan Capital from $40.00 to $18.00. They now have a "buy" rating on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at Piper Sandler from $110.00 to $81.00. They now have an "overweight" rating on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Co. plc (NASDAQ: PRTA) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating.
Ratings data for PRTA provided by MarketBeat
Prothena Corporation plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena Corporation plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $18.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $18.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) had its price target lowered by analysts at Piper Sandler from $81.00 to $15.00. They now have an "overweight" rating on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) was given a new $20.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) had its price target raised by analysts at HC Wainwright from $20.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for PRTA provided by MarketBeat
Neueste Beiträge
KacperGorecki in Discuss Wirtualna Polska Holding S.a.